DENDRID
LOE ApproachingNDAOPHTHALMICSOLUTION/DROPS
Approved
Jun 1963
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 17h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DENDRID is an ophthalmic solution approved in 1963 for eye conditions, representing a mature small-molecule product in the Alcon portfolio. The exact mechanism of action and indication are not specified in available data, but the product has maintained market presence for six decades. It is administered as eye drops for topical ocular treatment.
LOE Approaching
As a mature product approaching loss of exclusivity with moderate competitive pressure (30%), DENDRID likely supports a lean commercial team focused on retention and generic transition planning.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
DENDRID currently shows zero linked open positions, indicating minimal active hiring. Working on this product offers limited career acceleration and primarily involves defending market share and managing the transition to generic competition. Professionals seeking growth and visible impact should consider this a consolidation or exit role.
Brand ManagerField Sales Representative
Worked on DENDRID at Alcon? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.